Browse the corpus

REFERENCES American Academy of Pediatrics Committee on Drugs, “Transfer of Drugs and Other Chemicals Into Human Milk,” Pediatrics , 2001, 108(3):776-89. [PubMed 11533352 ] American Geriatrics Society 2012 Beers Criteria Update Expert Panel, "American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults," J Am Geriatr Soc , 2012, 60(4):616-31. [PubMed 22376048 ] Aronoff GR, Bennett WM, Berns JS, et al, Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 87. Barr J, Fraser G, Puntillo K, et al, “Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit,” Crit Care Med , 2013, 41(1):263-306. [PubMed 23269131 ] Cooney GF, Mochon M, Kaiser B, et al, “Effects of Carbamazepine on Cyclosporine Metabolism in Pediatric Renal Transplant Recipients,” Pharmacotherapy , 1995, 15(3):353-6. [PubMed 7667170 ] Furst SM and Uetrecht JP, “The Effect of Carbamazepine and Its Reactive Metabolite 9-Acridine Carboxaldehyde, on Immune Cell Function in vitro ,” Int J Immunopharmacol , 1995, 17(5):445-52. [PubMed 7591369 ] Gilman JT, “Carbamazepine Dosing for Pediatric Seizure Disorders: The Highs and Lows,” DICP , 1991, 25(10):1109-12. [PubMed 1803802 ] Hans P, Brichant JF, Pieron F, et al, “Elevated Plasma Alpha 1-Acid Glycoprotein Levels: Lack of Connection to Resistance to Vecuronium Blockade Induced by Anticonvulsant Therapy,” J Neurosurg Anesthesiol , 1997, 9(1):3-7. [PubMed 9016432 ] Iwahashi IS, Miyatake R, Suwaki H, et al, “The Drug-Drug Interaction Effects of Haloperidol on Plasma Carbamazepine Levels,” Clin Neuropharmacol , 1995, 18:233-6. [PubMed 8635181 ] Keating A and Blahunka P, “Carbamazepine-Induced Stevens-Johnson Syndrome in a Child,” Ann Pharmacother , 1995, 29(5):538-9. [PubMed 7655141 ] Ketter TA, Kalali AH, and Weisler RH, “A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes: SPD417 Study Group,” J Clin Psychiatry , 2004, 65(5):668-73. [PubMed 15163253 ] Korinthenberg R, Haug C, and Hannak D, “The Metabolization of Carbamazepine to CBZ-10,11 Epoxide in Children From the Newborn Age to Adolescence,” Neuropediatrics , 1994, 25(4):214-6. [PubMed 7824094 ]

Ketter TA, Kalali AH, and Weisler RH, “A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes: SPD417 Study Group,” J Clin Psychiatry , 2004, 65(5):668-73. [PubMed 15163253 ] Korinthenberg R, Haug C, and Hannak D, “The Metabolization of Carbamazepine to CBZ-10,11 Epoxide in Children From the Newborn Age to Adolescence,” Neuropediatrics , 1994, 25(4):214-6. [PubMed 7824094 ] Lerer B, Moore N, Meyendorff E, et al, “Carbamazepine Versus Lithium in Mania: A Double-Blind Study,” J Clin Psychiatry , 1987, 48(3):89-93. [PubMed 3546274 ] Liu H and Delgado MR, “Influence of Sex, Age, Weight, and Carbamazepine Dose on Serum Concentrations, Concentration Ratios, and Level/Dose Ratios of Carbamazepine and Its Metabolites,” Ther Drug Monit , 1994, 16(5):469-76. [PubMed 7846744 ] Matos ME, Burns MM, and Shannon MW, “False-Positive Tricyclic Antidepressant Drug Screen Results Leading to the Diagnosis of Carbamazepine Intoxication,” Pediatrics , 2000, 105(5):e66 [PubMed 10799630 ] McCormack M, Alfirevic A, Bourgeois S, et al, "HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans," N Engl J Med , 2011, 364(12):1134-43. [PubMed 21428769 ] Miles MV, Lawless ST, Tennison MB, et al, “Rapid Loading of Critically Ill Patients With Carbamazepine Suspension,” Pediatrics , 1990, 86(2):263-6. [PubMed 2371100 ] National Institute for Occupational Safety and Health (NIOSH), "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012." Available at file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf . Accessed January 21, 2013. Okuma T, Inanaga K, Otsuki S, et al, “Comparison of the Antimanic Efficacy of Carbamazepine and Chlorpromazine: A Double-Blind Controlled Study,” Psychopharmacology , 1979, 66(3):211-7. [PubMed 119267 ] Ory JP, Bourscheld D, Lebrun C, et al, “Drug-Induced Pseudolymphoma in a Lupus Patient: One Case Due to Carbamazepine,” Clin Exp Rheumatol , 1995, 12(Suppl 11):93. [PubMed 8162652 ] Patterson BD, “Possible Interaction Between Metronidazole and Carbamazepine,” Ann Pharmacother , 1994, 28(11):1303-4. [PubMed 7849350 ]

Okuma T, Inanaga K, Otsuki S, et al, “Comparison of the Antimanic Efficacy of Carbamazepine and Chlorpromazine: A Double-Blind Controlled Study,” Psychopharmacology , 1979, 66(3):211-7. [PubMed 119267 ] Ory JP, Bourscheld D, Lebrun C, et al, “Drug-Induced Pseudolymphoma in a Lupus Patient: One Case Due to Carbamazepine,” Clin Exp Rheumatol , 1995, 12(Suppl 11):93. [PubMed 8162652 ] Patterson BD, “Possible Interaction Between Metronidazole and Carbamazepine,” Ann Pharmacother , 1994, 28(11):1303-4. [PubMed 7849350 ] Placidi GF, Lenzi A, Lazzerini F, et al, “The Comparative Efficacy and Safety of Carbamazepine Versus Lithium: A Randomized, Double-blind 3-year Trial in 83 Patients,” J Clin Psychiatry , 1986, 47(10):490-4. [PubMed 3093468 ] Rabins PV, Blacker D, Rovner BW, et al, “American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,” Am J Psychiatry , 2007, 164(12 Suppl):5-56. Available at file://psychiatryonline.org/guidelines.aspx [PubMed 18340692 ] Richard A, Girard F, Girard DC, et al, “Cisatracurium-Induced Neuromuscular Blockade is Affected by Chronic Phenytoin or Carbamazepine Treatment in Neurosurgical Patients,” Anesth Analg , 2005, 100(2):538-44. [PubMed 15673889 ] Rispal P, Lasseur C, Labouyrie E, et al, “Pseudolymphoma-Induced by Carbamazepine. Report of Two Cases,” Rev Med Interne , 1995, 16(3):214-8. [PubMed 7740234 ] Soriano SG, Sullivan LJ, Venkatakrishnan K, et al, “Pharmacokinetics and Pharmacodynamics of Vecuronium in Children Receiving Phenytoin or Carbamazepine for Chronic Anticonvulsant Therapy,” Br J Anaesth , 2001, 86(2):223-9. [PubMed 11573664 ] Stafstrom CE, Nohria V, Loganbill H, et al, “Erythromycin-Induced Carbamazepine Toxicity: A Continuing Problem,” Arch Pediatr Adolesc Med , 1995, 149(1):99-101. [PubMed 7827672 ] Suppes T, Dennehy EB, Hirschfeld RMA, et al, “The Texas Implementation of Medication Algorithms: Update to the Algorithms for the Treatment of Bipolar I Disorder,” J Clin Psychiatry , 2005, 66(7):870-86. [PubMed 16013903 ] Tohen M, Castillo J, Baldessarini RJ, et al, “Blood Dyscrasias With Carbamazepine and Valproate: A Pharmacoepidemiological Study of 2,228 Patients at Risk,” Am J Psychiatry , 1995, 152(3):413-8. [PubMed 7864268 ]

Suppes T, Dennehy EB, Hirschfeld RMA, et al, “The Texas Implementation of Medication Algorithms: Update to the Algorithms for the Treatment of Bipolar I Disorder,” J Clin Psychiatry , 2005, 66(7):870-86. [PubMed 16013903 ] Tohen M, Castillo J, Baldessarini RJ, et al, “Blood Dyscrasias With Carbamazepine and Valproate: A Pharmacoepidemiological Study of 2,228 Patients at Risk,” Am J Psychiatry , 1995, 152(3):413-8. [PubMed 7864268 ] Weisler RH, Kalali AH, and Ketter TA, “A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Extended-Release Carbamazepine Capsules as Monotherapy for Bipolar Disorder Patients With Manic or Mixed Episodes: SPD417 Study Group,” J Clin Psychiatry , 2004, 65(4):478-84. [PubMed 15119909 ] Woolston JL, “Case Study: Carbamazepine Treatment of Juvenile-Onset Bipolar Disorder,” J Am Acad Child Adolesc Psychiatry , 1999, 38(3):335-8. [PubMed 10087696 ] Topic 9198 Version 59.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0505-91.202.164.29-A3F5C7E4D9-S244013.14]